These findings suggest a coordinated downregulation of circulating IGF‐1 and IGFBP‐3 in response to endurance exercise, which may help maintain circulating free IGF‐1 levels in humans with obesity during exercise. This evidence concerns the gene IGFBP3 and obesity disorder.